Publications by authors named "Carmine Musto"

Pulmonary embolism (PE) is commonly treated primarily with pharmacological therapy, while advanced reperfusion therapies (transcatheter or surgical) are considered only in cases of contraindications or failure of standard therapies. Treatment algorithms vary depending on the patient's risk, with patients at intermediate or high risk potentially requiring evaluation for such advanced reperfusion therapies. Critical scenarios, such as contraindications to systemic thrombolysis or failure of pharmacological protocols, necessitate the activation of a multidisciplinary pulmonary embolism response team (PERT) and prompt therapeutic escalation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the impact of gender on clinical outcomes after a 1-month dual-antiplatelet therapy (DAPT) period in patients at high bleeding risk undergoing percutaneous coronary intervention (PCI) with bioresorbable polymer everolimus-eluting stent (BP-EES).
  • The research found that while women had additional risk factors such as older age and lower hemoglobin levels, they did not show a significantly higher risk for serious complications compared to men after the 1-month DAPT period.
  • The results suggest that a short DAPT strategy post-PCI may be a safe and effective option for high bleeding risk women, indicating that sex may not be a critical factor in determining adverse outcomes in this context
View Article and Find Full Text PDF
Article Synopsis
  • A study collected data from 2,626 patients who underwent Transcatheter Aortic Valve Replacement (TAVR) in Italy from 2007 to 2017, focusing on those with normal or reduced Left Ventricular Ejection Fraction (LVEF).
  • Reduced LVEF patients were further divided into ischemic and nonischemic groups, with the main goal being to track all-cause death and rehospitalizations over 8 years.
  • Results showed that patients with reduced LVEF faced a higher risk of death and rehospitalizations, particularly those with an ischemic cause, highlighting the long-term challenges for these patients post-TAVR.
View Article and Find Full Text PDF

Introduction: Recent studies have shown gender differences in cardiovascular outcomes after left atrial appendage closure (LAAC), highlighting different complication rates and adverse events, particularly in short-term assessments. As a result, there remains a significant knowledge gap on how these differences directly impact the efficacy and safety of LAAC procedures. The aim of this retrospective study was to investigate the clinical outcomes of LAAC in women and men using the Watchman FLX device.

View Article and Find Full Text PDF

Background And Aims: Transcatheter aortic valve replacement (TAVR) determined a paradigm shift in the treatment of patients with severe symptomatic aortic stenosis but data on very long-term durability are lacking. We sought to evaluate the clinical and hemodynamic outcomes of the CoreValve porcine pericardial self-expanding bioprosthesis at 12-year follow-up.

Methods: 882 inoperable or high-risk patients were treated with the CoreValve bioprosthesis in 8 Italian high-volume centers between 2007 and 2011.

View Article and Find Full Text PDF
Article Synopsis
  • A study examined the effects of short dual antiplatelet therapy (S-DAPT) following percutaneous coronary intervention (PCI) in patients at high bleeding risk (HBR) using a specific heart health criteria (ARC-HBR).
  • The research involved 356 patients with a high prevalence of risk factors, showing that 5.2% experienced serious cardiac events within 12 months, while 2.7% had significant bleeding complications.
  • Findings suggest S-DAPT after using Synergy bioresorbable stents leads to favorable outcomes for both ischemic and bleeding events in high-risk patients, supporting previous positive results from the POEM trial.
View Article and Find Full Text PDF
Article Synopsis
  • The study reviews current literature on the outcomes of surgical aortic valve replacement (SAVR) versus transcatheter aortic valve replacement (TAVR) specifically for patients with bicuspid aortic stenosis (BAS), focusing on different valve morphologies in TAVR patients.
  • It analyzed eight studies comparing SAVR and TAVR outcomes, revealing no significant differences in death, stroke, or acute kidney injury rates between both methods, though TAVR had more permanent pacemaker implantations and SAVR had higher bleeding events.
  • The findings suggest that while TAVR is comparable to SAVR in short-term outcomes for BAS, it is associated with a higher rate of pacemaker use and lower rates of bleeding.
View Article and Find Full Text PDF

Background: Balloon post-dilation (BPD) is a widely adopted strategy to optimize acute results of TAVI, with a positive impact on both paravalvular leak and mean gradients. On the other hand, the inflation of the balloon inside prosthetic leaflets may damage them increasing the risk of structural valve deterioration (SVD). Furthermore, the impact of BPD on long-term clinical outcomes and valve hemodynamics is yet unknown.

View Article and Find Full Text PDF

Limited data are available about the impact of permanent pacemaker (PPM) implantation on long-term survival in patients with a bicuspid aortic valve (BAV) and severe aortic stenosis (AS) treated with transcatheter aortic valve replacement (TAVR). We aimed to evaluate the long-term clinical outcomes of patients with BAV with AS who underwent periprocedural PPM implantation after TAVR with a self-expandable prosthesis. Data from patients with BAV and severe AS who underwent TAVR between April 2009 and January 2022 and followed in the framework of the One Hospital ClinicalService-CoreValve Project were collected.

View Article and Find Full Text PDF

Background: Myocardial ischemia (INOCA) and acute myocardial infarction with non-obstructive coronary artery disease (MINOCA) represent emerging entities in the landscape of interventional cardiology. These conditions have heterogeneous pathophysiological mechanisms and clinical presentations, complex diagnostics, and high prognostic significance.

Methods: This survey was carried out jointly by the GISE Young Committee with the support of the SICI-GISE Society and the ICOT group with the aim of evaluating the implementation of diagnostic-therapeutic pathways in cases of suspected/confirmed INOCA and MINOCA diseases.

View Article and Find Full Text PDF
Article Synopsis
  • * 443 patients were enrolled, with no significant differences in the rates of serious heart issues like cardiac death and heart attacks between the ACS and CCS groups after 12 months.
  • * Both groups showed similar rates of bleeding complications, indicating that a 1-month DAPT approach is safe for HBR patients undergoing PCI with a specific type of stent (BP-EES).
View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter aortic valve replacement (TAVR) is effective for severe aortic valve stenosis, even in patients with low left ventricular ejection fraction (LVEF), but the effectiveness of specific TAVR devices in this group is unclear.
  • The LOSTAVI study analyzed 923 patients with varying levels of LVEF (<25%, 25-30%, 31-35%) and found that while in-hospital mortality rates were similar, patients with extremely low LVEF experienced more major adverse events.
  • At 12 months, reduced LVEF significantly impacted mortality and adverse events, confirming its importance in patient prognosis, while TAVR device type did not influence these outcomes.*
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the link between high postprocedural mean gradient (ppMG) and clinical events in patients with degenerative mitral regurgitation (DMR) after undergoing mitral valve transcatheter edge-to-edge repair (MV-TEER).
  • It included 371 patients and analyzed their outcomes based on different levels of ppMG, finding that while high ppMG alone wasn’t a strong predictor of adverse events, it was linked to increased residual mitral regurgitation (rMR).
  • The combination of elevated ppMG and significant rMR was associated with a higher risk of negative clinical outcomes, highlighting the importance of examining both factors together for patient prognosis.
View Article and Find Full Text PDF

Background: Over the past decades, the improvements in the diagnostic power and availability of non-invasive cardiac imaging techniques have led to a decline of right heart catheterization (RHC) performance. However, RHC remains the gold standard for diagnosing pulmonary hypertension and an essential tool for the evaluation of patient candidacy to heart transplantation.

Methods: This survey was carried out jointly by the Young Committee of GISE, with the support of the SICI-GISE Society, and the ICOT group, with the aim of evaluating how the interventional cardiology community perform RHC.

View Article and Find Full Text PDF

In the last decades, advances in percutaneous coronary intervention (PCI) strategies have significantly reduced the risk of procedural complications and in-hospital mortality of patients with acute coronary syndromes (ACS), thus increasing the population of stable post-ACS patients. This novel epidemiological scenario emphasizes the importance of implementing secondary preventive and follow-up strategies. The follow-up of patients after ACS or elective PCI should be based on common pathways and on the close collaboration between hospital cardiologists and primary care physicians.

View Article and Find Full Text PDF

Background: During the last decade, thanks to contemporary evidence and technological improvements, the role of interventional cardiology in the field of cardiac conditions that are mainly treated conservatively has grown a lot. In such scenario, drug-resistant arterial hypertension and heart failure (HF) have a significant role, considering the huge number of involved patients and their impact on mortality and quality of life.

Methods: This survey was jointly performed by the GISE Young Committee with the support of the SICI-GISE Society and the ICOT group with the aim of evaluating the view of the cardiology community on interventional therapies for arterial hypertension and HF.

View Article and Find Full Text PDF

Despite being highly effective in reducing residual mitral regurgitation and improving outcomes, mitral valve transcatheter edge-to-edge repair (MV-TEER) may be associated with high postprocedural residual mitral gradient (rMG). Conflicting results have been reported regarding the relation between rMG and adverse events. This study aimed to evaluate the predictors and the impact of elevated rMG after MV-TEER on clinical events in patients with functional mitral regurgitation (FMR) at 2 years follow-up.

View Article and Find Full Text PDF

Background: Data on left main (LM) percutaneous coronary interventions (PCI) have mostly been obtained in studies using drug-eluting stent (DES) platforms without dedicated large-vessel devices and with limited expansion capability.

Aims: Our study aimed to investigate the safety and efficacy of LM PCI with the latest-generation Resolute Onyx DES.

Methods: ROLEX (Revascularization Of LEft main with resolute onyX) is a prospective, multicentre study (ClinicalTrials.

View Article and Find Full Text PDF

Background: Complete revascularization (CR) of nonculprit lesions (NCL) is strongly recommended in patients with ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), but no definitive evidence is available regarding which diagnostic strategy should be preferred. Instantaneous wave-free ratio (iFR) has never been investigated in this setting. We aimed to describe clinical outcomes of a cohort of patients undergoing iFR-guided CR.

View Article and Find Full Text PDF

Background: Pulmonary embolism (PE) represents the third leading acute cardiovascular syndrome in the world and it is burdened with high mortality and morbidity rates. Percutaneous or catheter-based treatments of high- and intermediate-risk patients have garnered interest because of the limitations of both systemic thrombolysis and anticoagulation strategies. However, data on these techniques are heterogeneous and limited to small non-randomized evidences.

View Article and Find Full Text PDF

Background: Mitral-valve transcatheter edge-to-edge repair (MV-TEER) is recommended in patients with severe functional mitral regurgitation (FMR) and in those with degenerative mitral regurgitation (DMR) not eligible to traditional surgery. Patients with a history of previous cardiac surgery are considered at high risk for surgical reintervention, but data are lacking regarding procedural and clinical outcomes.

Objective: aim of this study was to assess the efficacy and clinical results of MV-TEER in patients with previous cardiac surgery enrolled in the "multicentre Italian Society of Interventional Cardiology registry of transcatheter treatment of mitral valve regurgitation" (GIOTTO).

View Article and Find Full Text PDF

Razionale. In Italia la pandemia COVID-19 ha determinato importanti riorganizzazioni logistiche nell'erogazione delle cure ospedaliere e di specialistica ambulatoriale. Ciò ha spinto clinici e decisori pubblico-amministrativi della Sanità ad adottare nuovi modelli organizzativi in molteplici scenari clinici.

View Article and Find Full Text PDF

Severe acute respiratory syndrome coronavirus-2 can affect the cardiovascular system yielding a wide range of complications, including acute myocardial injury. The myocardium can be damaged by direct viral invasion or indirect mechanisms, sustained by systemic inflammation, immune-mediated response, and dysregulation of the renin-angiotensin system. Myocardial injury affects about one-quarter of patients with COVID-19, can manifest even in the absence of previous cardiovascular disease, and is associated to higher mortality rates and long-term sequelae.

View Article and Find Full Text PDF

Left ventricular assist device (LVAD) obstruction can be a dramatic and life-threatening complication in patients with advanced heart failure (HF). Despite surgical redo is often required in these patients, it is associated with a high risk of periprocedural negative outcome. We report the case of a 68-year-old male with a thrombotic stenosis of the LVAD proximal outflow-graft.

View Article and Find Full Text PDF